Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Asiatic LaboratoriesDHA:ASIATICLAB +2.10%32 Operating Cash Flow per Share is BDT as of . 20. GuruFocus rates DHA:ASIATICLAB with a GF Score™ of 32/100. The stock has 1 warning sign investors should review. Among 760 Drug Manufacturers companies, Asiatic Laboratories ranks worse than 131578.82% on this metric.
Asiatic Laboratories's operating cash flow per share for the
six
months ended in . 20 was BDT0.00.
Asiatic Laboratories does not have enough years/quarters to calculate the operating cash flow per share for the trailing twelve months (TTM) ended in . 20.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.
The historical rank and industry rank for Asiatic Laboratories's Operating Cash Flow per Share or its related term are showing as below:
DHA:ASIATICLAB's 3-Year OCF Growth Rate is not ranked *
in the Drug Manufacturers industry.
Industry Median: 7.2 * Ranked among companies with meaningful 3-Year OCF Growth Rate only.
Asiatic Laboratories Operating Cash Flow per Share Related Terms
Asiatic Laboratories Operating Cash Flow per Share Historical Data
* Premium members only.
The historical data trend for Asiatic Laboratories's Operating Cash Flow per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Asiatic Laboratories Operating Cash Flow per Share Chart
Asiatic Laboratories Annual Data
Trend
Operating Cash Flow per Share
Asiatic Laboratories Semi-Annual Data
Operating Cash Flow per Share
DHA:ASIATICLAB vs ZTS, UTHR, VTRS: Operating Cash Flow per Share Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Asiatic Laboratories's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Asiatic Laboratories Price-to-Operating-Cash-Flow vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Asiatic Laboratories's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Asiatic Laboratories's Price-to-Operating-Cash-Flow falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Operating Cash Flow per Share of BDT mean?
Asiatic Laboratories (DHA:ASIATICLAB) has a Operating Cash Flow per Share of BDT as of . 20. Operating cash flow per share equals the per-share amount of cash flow from operations. View historical data on Asiatic Laboratories and its competitors. According to the industry distribution chart, Asiatic Laboratories ranks #999999 out of 760 companies in the Drug Manufacturers industry.
Is Asiatic Laboratories' Operating Cash Flow per Share too high?
Asiatic Laboratories' current Operating Cash Flow per Share is BDT. Based on the distribution chart, Asiatic Laboratories ranks #999999 out of 760 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Asiatic Laboratories has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Asiatic Laboratories' Operating Cash Flow per Share compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Asiatic Laboratories ranks #999999 out of 760 companies for Operating Cash Flow per Share. This places Asiatic Laboratories in the lower half of its industry. The industry median Operating Cash Flow per Share is 7.20. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Cash Flow per Share for a Drug Manufacturers company?
The median Operating Cash Flow per Share among Drug Manufacturers companies is 7.20, based on 760 companies in the industry. Companies in the top quartile (top 25%) have a Operating Cash Flow per Share significantly above this median, while those in the bottom quartile fall well below. However, Operating Cash Flow per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Cash Flow per Share mean?
A high Operating Cash Flow per Share can signal that a stock is expensive relative to its fundamentals. Operating cash flow per share equals the per-share amount of cash flow from operations. View historical data on Asiatic Laboratories and its competitors. For the Drug Manufacturers industry, the median Operating Cash Flow per Share is 7.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Asiatic Laboratories's current Operating Cash Flow per Share is BDT. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Asiatic Laboratories stock overvalued right now?
Asiatic Laboratories (DHA:ASIATICLAB) has a current Operating Cash Flow per Share of BDT. The current Operating Cash Flow per Share is BDT. Asiatic Laboratories' overall GF Score™ is 32/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Cash Flow per Share calculated?
Operating Cash Flow per Share is calculated from a company's financial statements. For Asiatic Laboratories (DHA:ASIATICLAB), the current Operating Cash Flow per Share is BDT as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Asiatic Laboratories Ltd is engaged in manufacturing and marketing of a wide range of the rapeutical medicines pharmaceutical products in the categories of Biological, Non-Biological & Sterile Pharmaceutical dosage. It has 80 generic molecules comprising therapeutic classes like antibiotics, antihistamines, bronchodilators, vitamins-minerals, antiulcerants, laxatives, gastroprokinetics, antihematinic, anthelmentics, CNS drugs, respiratory drugs, NSAIDs, dermatological preparations and sterile ophthalmic preparations.
32GF Score
Get the complete analysis for DHA:ASIATICLAB
Operating Cash Flow per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DHA:ASIATICLAB has been successfully added to your 
